- 专利标题： Hepatitis C virus inhibitors
-
申请号： US12569466申请日： 2009-09-29
-
公开(公告)号： US08383094B2公开(公告)日： 2013-02-26
- 发明人: Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
- 申请人： Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Pamela A. Mingo
- 主分类号： A61K38/20
- IPC分类号： A61K38/20 ; A61K38/21 ; A61K38/47 ; C07D413/04 ; C07D217/00 ; C07D215/00
摘要：
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
公开/授权文献
- US20100080772A1 Hepatitis C Virus Inhibitors 公开/授权日：2010-04-01
信息查询
IPC分类:
